Is iron-overload an independent prognostic factor in AML and MDS patients undergoing allogeneic stem cell transplantation?

被引：0
|
作者：
Wermke, M. [1 ]
Schmidt, A. [1 ]
Middeke, M. [1 ]
Sockel, K. [1 ]
von Bonin, M. [1 ]
Schoenefeldt, C. [1 ]
Plodeck, V [2 ]
Laniado, M. [2 ]
Schetelig, J. [1 ]
Ehninger, G. [1 ]
Bornhaeuser, M. [1 ]
Platzbecker, U. [1 ]
机构：
[1] Univ Klin Dresden, Med Klin 1, Dresden, Germany
[2] Univ Klin Dresden, Inst Radiol, Dresden, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [31] Hapoloidentical stem cell transplantation for MDS and MDS/AML
    Kim, Y. J.
    Shin, S. H.
    Yoon, J. H.
    Yahng, S. A.
    Lee, S. E.
    Hong, D. S.
    Park, J. W.
    LEUKEMIA RESEARCH, 2013, 37 : S120 - S120
  • [32] Clostridium Difficile infections in patients with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation identify high risk for adverse outcome
    Amberge, Simon
    Kramer, Michael
    Schroettner, Percy
    Heidrich, Katharina
    Schmelz, Renate
    Middeke, Jan M.
    Gunzer, Florian
    Hampe, Jochen
    Schetelig, Johannes
    Bornhaeuser, Martin
    Stoelzel, Friedrich
    BONE MARROW TRANSPLANTATION, 2020, 55 (02) : 367 - 375
  • [33] A pediatric prognostic score for patients undergoing allogeneic hematopoietic stem cell transplantation
    Arndt, Clemens
    Beck, James F.
    Gruhn, Bernd
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (06) : 509 - 515
  • [34] Trends in hospitalization outcomes of elderly patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia/myelodysplastic syndrome (AML/MDS).
    Murthy, Guru Subramanian Guru
    Mehta, Paulette
    Jethava, Yogesh
    Dhakal, Ishwori
    Makhoul, Issam
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] Allogeneic Stem Cell Transplantation for MDS
    Villar, Sara
    Robin, Marie
    HEMATO, 2021, 2 (03): : 545 - 555
  • [36] Clostridium Difficile infections in patients with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation identify high risk for adverse outcome
    Simon Amberge
    Michael Kramer
    Percy Schröttner
    Katharina Heidrich
    Renate Schmelz
    Jan M. Middeke
    Florian Gunzer
    Jochen Hampe
    Johannes Schetelig
    Martin Bornhäuser
    Friedrich Stölzel
    Bone Marrow Transplantation, 2020, 55 : 367 - 375
  • [37] Indications for allogeneic stem cell transplantation in patients with AML
    Passweg, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 227 - 227
  • [38] Microbiota analysis in allogeneic stem cell transplant patients with in AML and MDS
    Gurer, Ekin Ece
    Oguz, Fatma Savran
    Aktas, Zerrin
    Kalayoglu, Sevgi Besisik
    Oncul, Mustafa Oral
    Sezerman, Osman Ugur
    Ekren, Berkay
    Caliskan, Kader
    Gulbas, Zafer
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 326 - 326
  • [39] Iron-overload after autologous hematopoietic cell transplantation
    Majhail, Navneet S.
    DeFor, Todd E.
    Lazarus, Hillard M.
    Burns, Linda J.
    LEUKEMIA RESEARCH, 2009, 33 (04) : 578 - 579
  • [40] Allogeneic stem cell transplantation in patients with therapy-related MDS/AML following treatment with radioiodine
    Schroeder, T.
    Kroeger, N.
    Kuendgen, A.
    Platzbecker, U.
    Zohren, F.
    Haas, R.
    Fenk, R.
    Germing, U.
    Kobbe, G.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S370 - S370
12345